PCSA - What's Going On With Processa Pharmaceuticals (PCSA) Stock? | Benzinga
Processa Pharmaceuticals Inc (NASDAQ: PCSA) shares are trading lower by 21.7% to $0.64 Wednesday morning after the company said it recently had a meeting with the FDA about their Next Generation Capecitabine (NGC-Cap) for cancer patients.
The FDA provided guidance on designing ...
PCSA) Stock?>Full story available on Benzinga.com